Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Current Opinion in Drug Discovery & Development|April 23, 2008
Recent developments in de novo design and scaffold hoppingHarald Mauser, Wolfgang GubaJournal of Medicinal Chemistry|November 21, 2007
From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profilingWolfgang Guba, Luke G Green, Rainer E Martin, et al.Journal of Chemical Information and Modeling|June 1, 2005
Database clustering with a combination of fingerprint and maximum common substructure methodsMartin Stahl, Harald MauserJournal of Chemical Information and Modeling|February 16, 2007
Chemical fragment spaces for de novo designHarald Mauser, Martin StahlMini Reviews in Medicinal Chemistry|July 20, 2005
Computational chemistry as an integral component of lead generationOlivier Roche, Wolfgang GubaJournal of Molecular Modeling|May 2, 2008
ParaFrag--an approach for surface-based similarity comparison of molecular fragmentsArjen-Joachim Jakobi, Harald Mauser, Timothy ClarkDrug Discovery Today|April 4, 2006
Integrating molecular design resources within modern drug discovery research: the Roche experienceMartin Stahl, Wolfgang Guba, Manfred KansyBioorganic & Medicinal Chemistry Letters|March 5, 2005
Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry designWolfgang Guba, Werner Neidhart, Matthias NettekovenJournal of Chemical Information and Modeling|July 28, 2005
Prediction of UV and ESI-MS signal intensitiesHarald Mauser, Olivier Roche, Martin Stahl, et al.Journal of Medicinal Chemistry|June 25, 2005
A robust clustering method for chemical structuresMartin Stahl, Harald Mauser, Mark Tsui, et al.Pageof 7